437 related articles for article (PubMed ID: 7878023)
1. Mice deficient in cystathionine beta-synthase: animal models for mild and severe homocyst(e)inemia.
Watanabe M; Osada J; Aratani Y; Kluckman K; Reddick R; Malinow MR; Maeda N
Proc Natl Acad Sci U S A; 1995 Feb; 92(5):1585-9. PubMed ID: 7878023
[TBL] [Abstract][Full Text] [Related]
2. Protein-bound plasma homocyst(e)ine and identification of heterozygotes for cystathionine-synthase deficiency.
Sartorio R; Carrozzo R; Corbo L; Andria G
J Inherit Metab Dis; 1986; 9(1):25-9. PubMed ID: 3088321
[TBL] [Abstract][Full Text] [Related]
3. Protein-bound homocyst(e)ine in normal subjects and in patients with homocystinuria.
Kang SS; Wong PW; Becker N
Pediatr Res; 1979 Oct; 13(10):1141-3. PubMed ID: 503641
[TBL] [Abstract][Full Text] [Related]
4. Accumulation of homocyst(e)ine in vitamin B-6 deficiency: a model for the study of cystathionine beta-synthase deficiency.
Smolin LA; Benevenga NJ
J Nutr; 1982 Jul; 112(7):1264-72. PubMed ID: 7097345
[TBL] [Abstract][Full Text] [Related]
5. Factors affecting the accumulation of homocyst(e)ine in rats deficient in vitamin B-6.
Smolin LA; Benevenga NJ
J Nutr; 1984 Jan; 114(1):103-11. PubMed ID: 6537970
[TBL] [Abstract][Full Text] [Related]
6. Circulating lipid hydroperoxide levels in human hyperhomocysteinemia. Relevance to development of arteriosclerosis.
Dudman NP; Wilcken DE; Stocker R
Arterioscler Thromb; 1993 Apr; 13(4):512-6. PubMed ID: 8466886
[TBL] [Abstract][Full Text] [Related]
7. Genetic and nongenetic factors for moderate hyperhomocyst(e)inemia.
Kang SS; Wong PW
Atherosclerosis; 1996 Jan; 119(2):135-8. PubMed ID: 8808490
[TBL] [Abstract][Full Text] [Related]
8. Short-term folic acid supplementation induces variable and paradoxical changes in plasma homocyst(e)ine concentrations.
Malinow MR; Duell PB; Williams MA; Kruger WD; Evans AA; Anderson PH; Block PC; Hess DL; Upson BM; Graf EE; Irvin-Jones A; Wang L
Lipids; 2001; 36 Suppl():S27-32. PubMed ID: 11837988
[TBL] [Abstract][Full Text] [Related]
9. Tyrosinase inhibition due to interaction of homocyst(e)ine with copper: the mechanism for reversible hypopigmentation in homocystinuria due to cystathionine beta-synthase deficiency.
Reish O; Townsend D; Berry SA; Tsai MY; King RA
Am J Hum Genet; 1995 Jul; 57(1):127-32. PubMed ID: 7611281
[TBL] [Abstract][Full Text] [Related]
10. The association of elevated plasma homocyst(e)ine with progression of symptomatic peripheral arterial disease.
Taylor LM; DeFrang RD; Harris EJ; Porter JM
J Vasc Surg; 1991 Jan; 13(1):128-36. PubMed ID: 1987384
[TBL] [Abstract][Full Text] [Related]
11. Elevated plasma homocyst(e)ine concentration as a possible independent risk factor for stroke.
Coull BM; Malinow MR; Beamer N; Sexton G; Nordt F; de Garmo P
Stroke; 1990 Apr; 21(4):572-6. PubMed ID: 2326839
[TBL] [Abstract][Full Text] [Related]
12. Detection of heterozygotes for recessive alleles. Homocyst(e)inemia: paradigm of pitfalls in phenotypes.
McGill JJ; Mettler G; Rosenblatt DS; Scriver CR
Am J Med Genet; 1990 May; 36(1):45-52. PubMed ID: 2185635
[TBL] [Abstract][Full Text] [Related]
13. Homocyst(e)ine and atherosclerosis in patients on chronic hemodialysis.
Lee YK; Kwon YJ; Yoon JW; Oh KS; Cha DR; Cho WY; Huh K; Pyo HJ; Kim HK
J Korean Med Sci; 1999 Apr; 14(2):193-8. PubMed ID: 10331567
[TBL] [Abstract][Full Text] [Related]
14. Hyperhomocyst(e)inemia and the prevalence of atherosclerotic vascular disease in patients with end-stage renal disease.
Manns BJ; Burgess ED; Hyndman ME; Parsons HG; Schaefer JP; Scott-Douglas NW
Am J Kidney Dis; 1999 Oct; 34(4):669-77. PubMed ID: 10516348
[TBL] [Abstract][Full Text] [Related]
15. Effects of growth hormone (GH) administration on homocyst(e)ine levels in men with GH deficiency: a randomized controlled trial.
Sesmilo G; Biller BM; Llevadot J; Hayden D; Hanson G; Rifai N; Klibanski A
J Clin Endocrinol Metab; 2001 Apr; 86(4):1518-24. PubMed ID: 11297577
[TBL] [Abstract][Full Text] [Related]
16. Patients with atherosclerotic vascular disease: how low should plasma homocyst(e)ine levels go?
Spence JD
Am J Cardiovasc Drugs; 2001; 1(2):85-9. PubMed ID: 14728038
[TBL] [Abstract][Full Text] [Related]
17. Reduction of plasma homocyst(e)ine levels by breakfast cereal fortified with folic acid in patients with coronary heart disease.
Malinow MR; Duell PB; Hess DL; Anderson PH; Kruger WD; Phillipson BE; Gluckman RA; Block PC; Upson BM
N Engl J Med; 1998 Apr; 338(15):1009-15. PubMed ID: 9535664
[TBL] [Abstract][Full Text] [Related]
18. Hyperhomocyst(e)inemia and endothelial dysfunction in IDDM.
Hofmann MA; Kohl B; Zumbach MS; Borcea V; Bierhaus A; Henkels M; Amiral J; Fiehn W; Ziegler R; Wahl P; Nawroth PP
Diabetes Care; 1997 Dec; 20(12):1880-6. PubMed ID: 9405911
[TBL] [Abstract][Full Text] [Related]
19. Total homocyst(e)ine in plasma and amniotic fluid of pregnant women.
Kang SS; Wong PW; Zhou JM; Cook HY
Metabolism; 1986 Oct; 35(10):889-91. PubMed ID: 3762398
[TBL] [Abstract][Full Text] [Related]
20. Association between homocyst(e)ine levels and risk of vascular events.
Kaplan ED
Drugs Today (Barc); 2003 Mar; 39(3):175-92. PubMed ID: 12730702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
